What is the price target for TECX stock?
15 analysts have analysed TECX and the average price target is 79.82 USD. This implies a price increase of 170.47% is expected in the next year compared to the current price of 29.51.
TECTONIC THERAPEUTIC INC (TECX) Forecast, Price Target & Analyst Ratings
NASDAQ:TECX • US8789721086
Current stock price
29.51 USD
-0.17 (-0.57%)
At close:
29.51 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TECTONIC THERAPEUTIC INC (TECX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.21
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$79.82
Upside
+ 170.47%
From current price of $29.51 to mean target of $79.82, Based on 15 analyst forecasts
Low
$60.60
Median
$79.56
High
$106.05
Price Target Revisions
1 Month
-1.42%
3 Months
-2.03%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for TECX. The average price target is 79.82 USD. This implies a price increase of 170.47% is expected in the next year compared to the current price of 29.51.
The average price target has been revised downward by 2.03% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
TECX was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about TECX.
In the previous month the buy percentage consensus was at a similar level.
TECX was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | Stifel | Initiate | Buy |
| 2026-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-09-03 | Oppenheimer | Initiate | Outperform |
| 2025-07-21 | Truist Securities | Initiate | Buy |
| 2025-06-11 | Raymond James | Reiterate | Outperform |
| 2025-06-06 | LifeSci Capital | Initiate | Outperform |
| 2025-05-15 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-04-21 | Mizuho | Initiate | Outperform |
| 2025-03-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-20 | Raymond James | Initiate | Outperform |
| 2024-11-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-11 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-08-22 | Wells Fargo | Initiate | Overweight |
| 2024-07-24 | Leerink Partners | Initiate | Outperform |
| 2024-06-26 | Piper Sandler | Initiate | Overweight |
| 2024-06-24 | TD Cowen | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.21
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -29.73%
- Number of Analysts
- 10
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-3.31%
EPS (3 Months)
4.09%
Next Earnings Summary
TECX is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -1.21 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | ||||||
| EBITDA YoY % growth | N/A | N/A -70.63% | N/A -79.81% | -15.246M 88.25% | -31.824M -108.74% | -124.09M -289.93% | -56.37M 54.57% | -82.661M -46.64% | N/A -9.82% | N/A -17.98% | N/A | |
| EBIT YoY % growth | N/A | N/A -69.45% | N/A -74.68% | -15.61M 87.81% | -32.83M -110.31% | -125.568M -282.48% | -58.015M 53.80% | -84.036M -44.85% | N/A -11.76% | N/A -39.57% | N/A -24.55% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -32.16 16.63% | -39.72 -23.51% | -33.48 15.71% | -28.92 13.62% | -18.96 34.44% | -8.18 56.86% | -4.05 50.49% | N/A -23.91% | N/A -7.85% | N/A -5.80% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.21 -29.73% | -1.23 -14.55% | -1.27 -24.83% | -1.28 -24.61% | -1.50 -24.56% | -1.53 -24.83% | -1.52 -19.09% | -1.54 -19.74% |
| Revenue Q2Q % growth | ||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.019M -31.27% | -25.432M -13.88% | -27.158M -24.07% | -30.424M -41.40% | -43.401M -80.69% | -44.884M -76.49% | -44.825M -65.05% | -46.123M -51.60% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-12.24%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
TECTONIC THERAPEUTIC INC / TECX Forecast FAQ
Can you provide the upcoming earnings date for TECTONIC THERAPEUTIC INC?
TECTONIC THERAPEUTIC INC (TECX) will report earnings on 2026-05-07.
Can you provide the consensus estimates for TECTONIC THERAPEUTIC INC next earnings?
The consensus EPS estimate for the next earnings of TECTONIC THERAPEUTIC INC (TECX) is -1.21 USD and the consensus revenue estimate is 0 USD.